Skip to main content

In this Issue

  • Naloxone access, community efforts work to curb opioid abuse

    Drug overdoses have become the leading cause of accidental death in the United States, with 47,055 people dying in 2014 as a result of lethal drug overdoses — 18,893 of which were related to prescription pain relievers. The epidemic has drawn the attention of everyone from President Barack Obama to local first responders, all of whom have pointed to the drug naloxone as one of the critical first lines of defense in saving the lives of thousands from accidental overdose. Naloxone can reverse the effects of an overdose, but until recently it could only be accessed by prescription.

  • New earplugs relieve weather-related migraines

    COLD SPRING HARBOR, N.Y. — Cirrus Healthcare will be launching the clinically designed earplugs MigraineX, along with an app that tracks shifts in barometric pressure, a known trigger of migraines. “Weather causes migraines,” noted Lanny Lewis, SVP business development at Cirrus Healthcare, and not a lot of people know that. Cirrus is looking to change that, Lewis said.

  • Trends in men’s facial hair impact sales

    The shave category is trying to get its groove back. With the exception of razors, where sales are up a healthy 10.6% for the 52-week period ended Sept. 4, 2016, as tracked by IRI across multi-outlets, all of the other categories in shave are down.

    (To view the full Shave Report, click here.)

  • Living up to its mission

    About 20 years ago, I took a job as senior editor for Drug Store News. My first beat assignment was the OTC business and about a dozen retail companies, including CVS Pharmacy. Back then, CVS had just won the right to buy Revco, and it was making regular headlines in Drug Store News-FIRST — the weekly news-fax (remember those?) edition of DSN that would later become our daily e-newsletter DSN A.M. — as it completed the biggest integration of stores and systems in the history of the retail pharmacy business.

  • Nexium 24HR remains leader ahead of private-label launches

    Pfizer’s Nexium 24HR is the clear leader in the digestive aisle. However, in March 2017, store-brand versions of Nexium 24HR will be available. Perrigo has already secured a tentative approval from the Food and Drug Administration for its OTC Nexium 24HR generic equivalent. “We are currently working with our retail customers in making plans to launch the item as soon as possible after the late March 2017 market exclusivity period expires for the national brand,” John Henderickson, Perrigo president and CEO, recently told investors.

  • One-size-fits-none: Creating personalized solutions for tech savvy boomers

    One of the biggest impacts of technology among a potentially unexpected group of consumers is its ability to empower baby boomers to be independent for longer, according to Pfizer Consumer Healthcare senior director disruptive innovation wellness Rimma Fehling. Baby boomers are becoming the beneficiaries of extended independence as the result of technological advances that can cover physical distance with technological solutions.

  • Higi: Empowering patients with information

    How can pharmacy retailers and their vendor partners help make health care more accountable, accessible and cost-effective? And what role can they play to help their customers to lead longer, healthier lives?

  • Consumer use of natural OTCs increases

    The use of homeopathic medicines as part of a self-care solution to treat such ailments as the common cold or back pain is becoming more and more commonplace through conventional channels. While a Harvard survey on the use of homeopathy published earlier this year in the American Journal of Public Health revealed that only 2.1% of U.S. adults have used homeopathy in the past 12 months, conventional outlets including Walmart, CVS Health and Rite Aid command 86.5% of the homeopathic dollar share, according to SPINSscan (powered by IRI).

X
This ad will auto-close in 10 seconds